Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05122728 · ClinicalTrials.gov registry record
Post-Concussion Musculoskeletal Injury Risks
A clinical trial of Musculoskeletal Injury, sponsored by Walter Reed National Military Medical Center.
- Recruiting
- Registry status
- 148
- Enrollment target
- 3
- Study locations
NCT05122728: Recruiting study of Musculoskeletal Injury, sponsored by Walter Reed National Military Medical Center.
NCT05122728 is a study of Musculoskeletal Injury that is actively recruiting participants, run by Walter Reed National Military Medical Center. The registered enrollment target is 148 participants, below the 512-participant average among 15 other Musculoskeletal Injury trials with a reported enrollment target (71% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05122728, a study of Musculoskeletal Injury, is actively recruiting participants, sponsored by Walter Reed National Military Medical Center.
- RECRUITING
- Registry status
- 148 participants
- Enrollment target
- 3
- Study locations
Study Summary
Musculoskeletal injuries (MSKI) and traumatic brain injury (TBI) are the signature injuries of the ongoing military conflicts. MSKI affect 800,000 Service Members annually and TBI have impacted more than 350,000 in the past 19 years and account for 22% of all combat casualties. Concussion, a mild form of TBI, increases MSKI risk in physically active individuals, including Service Members. The overall goal of the study is to identify the neuromuscular control mechanisms that increase MSKI risk following concussion. It is hypothesized that concussed individuals will display abnormal neuromuscular function that increases MSKI risk, as compared to non-concussed controls. The study will employ a multi-center, prospective, case-matched control observational study to identify the differences in neuromuscular function following concussion that may contribute to increased MSKI risk. Once the neuromuscular control mechanisms that increase MSKI risk following concussion are identified, targeted risk mitigation strategies can be developed to reduce MSKI risk.
Primary Outcome
The participant will stand on a 30cm tall box, set at a distance that is equal to 50% of the participant's height behind a set of force platforms. Once the participant receives a visual stimulus, he/she will jump so that both feet leave the box at the same time. Upon landing the participant will immediately jump vertically for maximal height. Participants will complete 5 jump-landings. Whole body biomechanics will be collected and kinematic and kinetic measures will be identified at initial grou
Conditions Studied
Interventions
- OTHER Post-Concussion Neuromuscular Function and Musculoskeletal Injury Risk Assessment
Study Locations (3)
Georgia
- University of Georgia - Athens
Maryland
- Walter Reed National Military Medical Center - Bethesda
North Carolina
- Womack Army Medical Center - Fort Bragg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2022-10-20 |
| Est. Completion | 2027-09-30 |
What NCT05122728 shows while recruiting
NCT05122728 is an observational study that tracks outcomes without assigning an intervention. The registered 148 participants enrollment target is mid-sized for trials with a published cap, below the 512-participant average among 15 other Musculoskeletal Injury trials with a reported enrollment target (71% lower).
The record links to 1 condition, with Musculoskeletal Injury appearing as the primary indexed condition, and to 1 intervention - of which Post-Concussion Neuromuscular Function and Musculoskeletal Injury Risk Assessment is the first listed.
NCT05122728 reports a single indexed study location in Georgia, Maryland, North Carolina.
Frequently Asked Questions
What is clinical trial NCT05122728 about?
NCT05122728 is a clinical study titled "Post-Concussion Musculoskeletal Injury Risks". Musculoskeletal injuries (MSKI) and traumatic brain injury (TBI) are the signature injuries of the ongoing military conflicts. MSKI affect 800,000 Service Members annually and TBI have impacted more than 350,000 in the past 19 years and account for 22% of all combat casualties. Concussion, a mild fo...
What is the current status of trial NCT05122728?
This trial is currently recruiting. The enrollment target is 148 participants. The study started on 2022-10-20. Estimated completion is 2027-09-30.
What conditions does trial NCT05122728 study?
This clinical trial studies the following conditions: Musculoskeletal Injury.
What interventions are being tested in trial NCT05122728?
The interventions under investigation include: Post-Concussion Neuromuscular Function and Musculoskeletal Injury Risk Assessment (OTHER).
Who is sponsoring clinical trial NCT05122728?
This trial is sponsored by Walter Reed National Military Medical Center, which has 48 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05122728 being conducted?
This trial has 3 study locations across Georgia, Maryland, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Musculoskeletal Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05122728's enrollment target sits among peer trials
148 7th of 15 higher than 9 of 15 other Musculoskeletal Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Musculoskeletal Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Effects of AFO Heel Height and Stiffness on Gait
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Use of an Integrated Orthotic and Rehabilitation Initiative for Treatment of Lower Extremity Musculoskeletal Disorders
RECRUITING
-
Adaptions and Resiliency to Multi-Stressor OpeRations
RECRUITING · Phase 4
-
Quality of Life and Life Satisfaction in Pediatric and Adolescent Gymnasts Through Injury
RECRUITING
-
Baseline ACL Injury Risk Screening and Normative Data
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00739362 · 148 participants · Phase 2
Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment
- NCT03161223 · 148 participants · Phase 1
Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma
- NCT03858231 · 148 participants · Phase 4
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
- NCT04486352 · 148 participants · Phase 1
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI